Karvy Stock Broking Limited has maintained 'Buy' rating on Opto Circuits India stock to achieve a target of Rs 210 in 1-2 trading sessions.

According to Karvy, interested traders can buy the stock between Rs 200-203 with a strict stop loss of Rs 195.

On Wednesday (Oct 07), the shares of the company closed at Rs 202.65 on the Bombay Stock Exchange (BSE). The share price has seen a 52-week high of Rs 212.90 and a low of Rs 69.50 on BSE. Current EPS and P/E of the stock stood at 8.58 & 23.62 respectively.

Medical diagnostic equipment maker Opto Circuits India on Sep 30 announced that US arm, Criticare Systems Inc (CSI) has entered into a multi-year original equipment developing agreement with another US-based company to privately label its anaesthesia monitor for the US company.

On Sep 24, Criticare Systems Inc (CSI) signed up a long term deal with a European company for supplying patient monitoring systems and anesthetic gas delivery products.

The deal consists of the supply of private label patient monitoring systems by CSI to the partner in addition to collaboration in sales and delivery of anesthetic gas delivery products in European and US markets.

Opto Circuits India, on Sep 22, lifted up around Rs 4 billion via issue of shares to QIBs on a private placement basis.

On Sep 15, Opto Circuits allotted 21.4 million shares under QIP carrying a price of Rs 186.65 per share.